Key Highlights
- Jupiter Neurosciences shares closed down 26% at $0.08.
- The company finalized a 1-for-75 reverse stock split scheduled for August 6, 2026.
- Adjusted trading is set to commence the following day under its existing ticker.
- The move is intended to satisfy Nasdaq minimum bid price requirements for continued listing.
Jupiter Neurosciences (NASDAQ: JUNS) shares closed down 26% at $0.08 after the company finalized a 1-for-75 reverse stock split scheduled for August 6, 2026, with adjusted trading commencing the following day under its existing ticker.
What Happened
The strategic maneuver is intended to satisfy Nasdaq minimum bid price requirements for continued listing, with the company opting to settle any resulting fractional shares through cash payments.
Market Reaction
Shares fell sharply ahead of the reverse split, a common pattern for stocks facing Nasdaq listing compliance pressure, as the market adjusts to the anticipated post-split share structure.
Outlook
Adjusted trading is set to commence the day after the split takes effect; investors are likely to watch how the stock behaves under its new post-split share count relative to Nasdaq's minimum bid price requirement.
Why did Jupiter Neurosciences finalize a reverse stock split?
To satisfy Nasdaq minimum bid price requirements for continued listing.
What is the ratio of the reverse stock split?
1-for-75.
How will fractional shares be handled?
The company will settle any resulting fractional shares through cash payments.



_11_19_2026_18_10_09_455845.jpg)

_11_19_2026_18_15_38_890267.jpg)
Please wait processing your request...